Literature DB >> 9554372

Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer.

R Iantorno1, M Nicolai, M L Storto, C Ciccotosto, G Cipollone, G Mastroprimiano, R L Tenaglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9554372     DOI： 10.1097/00005392-199805000-00063

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

Authors:  Chang-Ho Ryan Choi; Sang Oh Lee; Geoff Smith
Journal:  BMJ Case Rep       Date:  2014-05-08

2.  Systemic granulomatous reaction secondary to treatment of bladder cancer with bacillus calmette-guerin.

Authors:  Caterina Giovanna Valentini; Valentina Bozzoli; Anna Rita Larici; Luigi Maria Larocca; Giovanni Delogu; Giuseppe Leone; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-06-18       Impact factor: 2.576

Review 3.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

4.  Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.

Authors:  Kyohei Kaburaki; Keishi Sugino; Muneyuki Sekiya; Yujiro Takai; Kazutoshi Shibuya; Sakae Homma
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.